Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Mar;20(3):174-176.
doi: 10.1089/dia.2018.0038.

Ongoing Debate About Models for Artificial Pancreas Systems and In Silico Studies

Affiliations
Comment

Ongoing Debate About Models for Artificial Pancreas Systems and In Silico Studies

Gregory P Forlenza. Diabetes Technol Ther. 2018 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

G.P.F. conducts research sponsored by Medtronic, Dexcom, Abbott, Tandem, Insulet, Bigfoot, BetaBionics, and Type Zero, and has been a consultant or advisory board member for Dexcom, Abbott, and Tandem.

Comment on

References

    1. Steil GM: Algorithms for a closed-loop artificial pancreas: the case for proportional-integral-derivative control. J Diabetes Sci Technol 2013;7:1621–1631 - PMC - PubMed
    1. Bequette BW: Algorithms for a closed-loop artificial pancreas: the case for model predictive control. J Diabetes Sci Technol 2013;7:1632–1643 - PMC - PubMed
    1. Bergenstal RM, Garg S, Weinzimer SA, et al. : Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 2016;316:1407–1408 - PubMed
    1. Garg SK, Weinzimer SA, Tamborlane WV, et al. : Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 2017;19:155–163 - PMC - PubMed
    1. Weisman A, Bai JW, Cardinez M, et al. : Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol 2017;5:501–512 - PubMed

Publication types

LinkOut - more resources